Remantadin®

Remantadin®

Active substance:Rimantadini hydrochloridum

Indications: Therapy of influenza and prevention thereof, prevention of tick-borne encephalitis

Dose and quantity:  50 mg N20

Pharmaceutical form: Tablets

Product ATC Code: J05AC02

Product Description

Antiviral agent – amantadine derivative.

Remantadin® is effective against influenza viruses of type A, as well as has an anti – toxic effect in cases of intoxication caused by influenza virus of type B. Remantadin® inhibits the viral replication cycle in early phases, possibly, by delaying the development of a viral capsid. Remantadin® is effective against flaviviruses caused by tick – borne encephalitis.

Therapeutic indications:

  • Early treatment of influenza virus infection in adults and children over 7 years of age
  • Prevention during influenza epidemic for adults and children from the age of 7 years old

Instructions